HUTCHMED (China) Limited (HCM) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Hutchmed (china) Limited.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.080 Hello everyone, this is David Nguyen, head of investor relation of HodgeMet. 00:00:05.080 -- 00:00:08.140 Thank you for joining HodgeMet 2025 00:00:08.140 -- 00:00:10.880 interim result presentation. 00:00:10.880 -- 00:00:16.120 Our results and presentation slides have already been posted on our homepage, 00:00:16.120 -- 00:00:20.180 as well as on the Hong Kong Stock Exchange website. 00:00:20.180 -- 00:00:23.700 Just a quick moment on the disclaimer. 00:00:23.700 -- 00:00:28.260 The performance and results of operation of HodgeMet Group contained within this presentation 00:00:28.260 -- 00:00:32.920 are historical in nature, and past performance is no guarantee of future results, and 00:00:32.920 -- 00:00:38.820 actual result may vary materially from those set forth in the forward-looking statement. 00:00:38.820 -- 00:00:43.720 So today we are very glad to have our CEO, Dr. 00:00:43.720 -- 00:00:48.740 Su, our CFO, Mr. Chan, our CMO, 00:00:48.740 -- 00:00:53.980 Dr. Shi and our head of commercial, Mr. Yuan, to go over the results 00:00:53.980 -- 00:00:57.980 and provide the latest update on our performance. 00:00:57.980 -- 00:01:03.200 And the projects and the development. As usual, we will have a Q&A session 00:01:03.200 -- 00:01:08.300 at the very end, when you can press the raise head button to ask questions and 00:01:08.300 -- 00:01:12.700 or type in the chat box, but please make sure you have your name and your company name 00:01:12.700 -- 00:01:17.920 on the screen. So now let us welcome our chief executive 00:01:17.920 -- 00:01:23.740 officer and chief scientific officer, Dr. Wei-Wu Su to begin our presentation. 00:01:23.740 -- 00:01:25.540 Dr. Su. 00:01:25.540 -- 00:01:29.820 Thank you, David. If we go to the next slide. 0...